Literature DB >> 21748289

A population-based analysis on the rate and surgical management of colorectal liver metastases in Southern Germany.

Christina Hackl1, Michael Gerken, Martin Loss, Monika Klinkhammer-Schalke, Pompiliu Piso, Hans J Schlitt.   

Abstract

PURPOSE: Early detection and multidisciplinary treatment of colorectal liver metastases (CLM), preferably resection, can significantly prolong the survival of colorectal cancer patients. The purpose of this study was to analyze the incidence, management and long-term clinical outcome of CLM patients using data from a regional German tumour registry.
METHODS: We conducted a retrospective analysis of 884 patients diagnosed with colorectal adenocarcinoma in the year 2002 and documented in a regional tumor registry in Southern Germany.
RESULTS: Two hundred thirty-six patients (26.7%) had or developed CLM, 132 patients (14.9%) had synchronous CLM and 104 patients (11.8%) developed metachronous CLM. At diagnosis of CLM, 86 patients (36.4%) had 3 or less documented lesions, 6 patients (2.5%) had 4 to 6 lesions and 89 patients (37.7%) showed multiple, diffuse metastases; for 55 patients (23.3%), the number of lesions was not specified. CLM patients (19.1%) (5.1% of all patients) underwent liver resection; a higher resection rate (28.3%) was observed in a subgroup of patients treated in two academic centres. Patients without CLM had a significantly better 5-year survival rate than patients with liver metastases (65.5% versus 16.3%). CLM patients with up to 3 liver metastases (i.e., potentially resectable) who underwent liver resection (n=34) showed a significantly higher 5-year survival than non-resected (n=52) patients (40% versus 5%).
CONCLUSIONS: The present study is the first population-based analysis of the surgical management and outcome of CLM in Southern Germany. The percentage of liver resections was lower than expected, particularly for patients with three or less metastases. The present data suggest that relevant undertreatment of CLM patients may occur which may have a negative impact on survival.

Entities:  

Mesh:

Year:  2011        PMID: 21748289     DOI: 10.1007/s00384-011-1278-5

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  17 in total

1.  Improving resectability of hepatic colorectal metastases: expert consensus statement.

Authors:  Eddie K Abdalla; René Adam; Anton J Bilchik; Daniel Jaeck; Jean-Nicolas Vauthey; David Mahvi
Journal:  Ann Surg Oncol       Date:  2006-09-06       Impact factor: 5.344

Review 2.  [Update S3-guideline "colorectal cancer" 2008].

Authors:  W Schmiegel; A Reinacher-Schick; D Arnold; U Graeven; V Heinemann; R Porschen; J Riemann; C Rödel; R Sauer; M Wieser; W Schmitt; H-J Schmoll; T Seufferlein; I Kopp; C Pox
Journal:  Z Gastroenterol       Date:  2008-08       Impact factor: 2.000

3.  Epidemiology and management of liver metastases from colorectal cancer.

Authors:  Sylvain Manfredi; Côme Lepage; Cyril Hatem; Olivier Coatmeur; Jean Faivre; Anne-Marie Bouvier
Journal:  Ann Surg       Date:  2006-08       Impact factor: 12.969

4.  Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history.

Authors:  J Scheele; R Stangl; A Altendorf-Hofmann
Journal:  Br J Surg       Date:  1990-11       Impact factor: 6.939

5.  The potential for improved outcome in patients with hepatic metastases from colon cancer: a population-based study.

Authors:  A Sjövall; V Järv; L Blomqvist; T Singnomklao; B Cedermark; B Glimelius; T Holm
Journal:  Eur J Surg Oncol       Date:  2004-10       Impact factor: 4.424

6.  Actual 10-year survival after resection of colorectal liver metastases defines cure.

Authors:  James S Tomlinson; William R Jarnagin; Ronald P DeMatteo; Yuman Fong; Peter Kornprat; Mithat Gonen; Nancy Kemeny; Murray F Brennan; Leslie H Blumgart; Michael D'Angelica
Journal:  J Clin Oncol       Date:  2007-10-10       Impact factor: 44.544

7.  Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.

Authors:  Herbert Hurwitz; Louis Fehrenbacher; William Novotny; Thomas Cartwright; John Hainsworth; William Heim; Jordan Berlin; Ari Baron; Susan Griffing; Eric Holmgren; Napoleone Ferrara; Gwen Fyfe; Beth Rogers; Robert Ross; Fairooz Kabbinavar
Journal:  N Engl J Med       Date:  2004-06-03       Impact factor: 91.245

8.  New paradigm in the management of liver-only metastases from colorectal cancer.

Authors:  Matteo Donadon; Dario Ribero; Gareth Morris-Stiff; Eddie K Abdalla; Jean-Nicolas Vauthey
Journal:  Gastrointest Cancer Res       Date:  2007-01

9.  Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade.

Authors:  William R Jarnagin; Mithat Gonen; Yuman Fong; Ronald P DeMatteo; Leah Ben-Porat; Sarah Little; Carlos Corvera; Sharon Weber; Leslie H Blumgart
Journal:  Ann Surg       Date:  2002-10       Impact factor: 12.969

10.  A population-based study of the incidence, management and prognosis of hepatic metastases from colorectal cancer.

Authors:  J Leporrier; J Maurel; L Chiche; S Bara; P Segol; G Launoy
Journal:  Br J Surg       Date:  2006-04       Impact factor: 6.939

View more
  11 in total

Review 1.  Current status of transarterial radioembolization.

Authors:  Andreas H Mahnken
Journal:  World J Radiol       Date:  2016-05-28

2.  Nationwide trends in incidence, treatment and survival of colorectal cancer patients with synchronous metastases.

Authors:  Lydia G M van der Geest; Jorine't Lam-Boer; Miriam Koopman; Cees Verhoef; Marloes A G Elferink; Johannes H W de Wilt
Journal:  Clin Exp Metastasis       Date:  2015-04-22       Impact factor: 5.150

3.  Salvage RFA in patients with intrahepatic recurrence after major hepatic surgery for colorectal cancer liver metastases: mid-term outcome.

Authors:  Markus Zimmermann; Federico Pedersoli; Maximilian Schulze-Hagen; Georg Lurje; Peter Isfort; Christiane Kuhl; Philipp Bruners
Journal:  Eur Radiol       Date:  2019-09-06       Impact factor: 5.315

Review 4.  Liver transplantation for malignancy: current treatment strategies and future perspectives.

Authors:  Christina Hackl; Hans J Schlitt; Gabriele I Kirchner; Birgit Knoppke; Martin Loss
Journal:  World J Gastroenterol       Date:  2014-05-14       Impact factor: 5.742

5.  Treatment of colorectal liver metastases in Germany: a ten-year population-based analysis of 5772 cases of primary colorectal adenocarcinoma.

Authors:  Christina Hackl; Peter Neumann; Michael Gerken; Martin Loss; Monika Klinkhammer-Schalke; Hans J Schlitt
Journal:  BMC Cancer       Date:  2014-11-04       Impact factor: 4.430

6.  Systematic failure to operate on colorectal cancer liver metastases in California.

Authors:  Mustafa Raoof; Zeljka Jutric; Sidra Haye; Philip H G Ituarte; Beiqun Zhao; Gagandeep Singh; Laleh Melstrom; Susanne G Warner; Bryan Clary; Yuman Fong
Journal:  Cancer Med       Date:  2020-07-20       Impact factor: 4.452

Review 7.  The Role of Tumor-Associated Neutrophils in Colorectal Cancer.

Authors:  Rei Mizuno; Kenji Kawada; Yoshiro Itatani; Ryotaro Ogawa; Yoshiyuki Kiyasu; Yoshiharu Sakai
Journal:  Int J Mol Sci       Date:  2019-01-27       Impact factor: 5.923

8.  HER-2 and HER-3 expression in liver metastases of patients with colorectal cancer.

Authors:  Hanna Styczen; Iris Nagelmeier; Tim Beissbarth; Manuel Nietert; Kia Homayounfar; Thilo Sprenger; Ute Boczek; Kathrin Stanek; Julia Kitz; Hendrik A Wolff; B Michael Ghadimi; Peter Middel; Torsten Liersch; Josef Rüschoff; Lena-Christin Conradi
Journal:  Oncotarget       Date:  2015-06-20

9.  Metastatic recurrence after complete resection of colorectal liver metastases: impact of surgery and chemotherapy on survival.

Authors:  K Homayounfar; A Bleckmann; L C Conradi; T Sprenger; T Lorf; M Niessner; C O Sahlmann; J Meller; T Liersch; B M Ghadimi
Journal:  Int J Colorectal Dis       Date:  2013-02-01       Impact factor: 2.571

10.  FIRST BRAZILIAN CONSENSUS ON MULTIMODAL TREATMENT OF COLORECTAL LIVER METASTASES. MODULE 1: PRE-TREATMENT EVALUATION.

Authors:  Felipe José Fernandez Coimbra; Heber Salvador de Castro Ribeiro; Márcio Carmona Marques; Paulo Herman; Rubens Chojniak; Antonio Nocchi Kalil; Evanius Garcia Wiermann; Sandro Roberto de Araújo Cavallero; Fabricio Ferreira Coelho; Paulo Henrique de Souza Fernandes; Anderson Arantes Silvestrini; Maria Fernanda Arruda Almeida; Antônio Luis Eiras de Araújo; Marcos Pitombo; Heberton Medeiros Teixeira; Fábio Luiz Waechter; Fábio Gonçalves Ferreira; Alessandro Landskron Diniz; Giuseppe D'Ippolito; Giuseppe D'Ippolito; Maria Dirlei F de Sousa Begnami; Gabriel Prolla; Silvio Márcio Pegoraro Balzan; Thiago Bueno de Oliveira; Luís Arnaldo Szultan; Javier Lendoire; Orlando Jorge Martins Torres
Journal:  Arq Bras Cir Dig       Date:  2015 Nov-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.